Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (2037)	11/13/2000 5:43:17 PM
From: Biomaven	Respond to of 52153

Chuckle. Well given the election and the market, we may as well enjoy some humor instead. :% (twisted smile). TSC had some response to the Baron's article from Mike King (biotech is not internet) and David Saks ("great buying opportunity"). thestreet.com The simple difference between the dot.coms and the biotechs is that the biotechs have a known business model that on average works. Individual biotechs will always be very risky. This does not mean that a basket of biotechs is fundamentally risky, although there will still be stock price volatility in the basket. Peter